Back to User profile » Dr Wei-Dong Wang
Papers published by Dr Wei-Dong Wang:
Construction of a Prognostic Model Based on Insulin Resistance-Related Genes to Predict TACE Response and Identification of PD-98059 as a Potential Therapeutic Agent
Wang W, Chen K, Fan C, Sun L, Tang H, Ding W, Sun F, Wang W
Journal of Hepatocellular Carcinoma 2026, 13:553710
Published Date: 21 January 2026
The Value of Neutrophil-to-Lymphocyte Ratio in Predicting Mortality After Transjugular Intrahepatic Portosystemic Shunt Placement
Tang HH, Zhou LF, Wang CX, Zha Y, Fan C, Zhong BY, Zhu XL, Wang WD
Journal of Inflammation Research 2024, 17:5211-5221
Published Date: 1 August 2024
The Safety and Efficacy of Hepatic Arterial Infusion Chemotherapy Combined with PD-(L)1 Inhibitors and Molecular Targeted Therapies for the Treatment of Intermediate and Advanced Hepatocellular Carcinoma Unsuitable for Transarterial Chemoembolization
Tang HH, Zhang MQ, Zhang ZC, Fan C, Jin Y, Wang WD
Journal of Hepatocellular Carcinoma 2023, 10:2211-2221
Published Date: 12 December 2023
Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7
Jiang JQ, Huang JT, Zhong BY, Wang WD, Sun JH, Wang Q, Ding WB, Ni CF, Zhu XL
Journal of Hepatocellular Carcinoma 2023, 10:1629-1638
Published Date: 26 September 2023
Perioperative and Postoperative Complications of Supraclavicular, Ultrasound-Guided, Totally Implantable Venous Access Port via the Brachiocephalic Vein in Adult Patients: A Retrospective Multicentre Study
Yu Z, Sun X, Bai X, Ding W, Wang W, Xu L, Qin W, Wen L, Jin Y
Therapeutics and Clinical Risk Management 2021, 17:137-144
Published Date: 4 February 2021